Karl Frank

543 total citations
17 papers, 362 citations indexed

About

Karl Frank is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Karl Frank has authored 17 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 7 papers in Molecular Biology and 5 papers in Virology. Recurrent topics in Karl Frank's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (5 papers) and Herpesvirus Infections and Treatments (4 papers). Karl Frank is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (5 papers) and Herpesvirus Infections and Treatments (4 papers). Karl Frank collaborates with scholars based in United States and Switzerland. Karl Frank's co-authors include Ying‐Chih Cheng, Iain S. Sim, Y C Cheng, Kenneth F. Bastow, David Derse, S F Le Grice, Kathryn J. Howard, Yung‐Chi Cheng, Patricia A. McKernan and Donald F. Smee and has published in prestigious journals such as Journal of Biological Chemistry, Annals of the New York Academy of Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Karl Frank

17 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Frank United States 11 161 139 112 89 57 17 362
Bryan O’Hara United States 11 238 1.5× 74 0.5× 130 1.2× 35 0.4× 33 0.6× 13 385
Karen Prus United States 9 112 0.7× 202 1.5× 146 1.3× 137 1.5× 52 0.9× 17 398
Dean W. Selleseth United States 11 188 1.2× 111 0.8× 79 0.7× 76 0.9× 50 0.9× 16 435
Iain S. Sim United States 11 219 1.4× 204 1.5× 218 1.9× 105 1.2× 28 0.5× 25 565
Galegov Ga Russia 11 169 1.0× 89 0.6× 139 1.2× 33 0.4× 20 0.4× 103 382
Gussie Arnett United States 12 174 1.1× 192 1.4× 255 2.3× 59 0.7× 61 1.1× 20 507
Yvonne A. Wilson United States 7 108 0.7× 212 1.5× 179 1.6× 174 2.0× 19 0.3× 7 490
Christine L. Clouser United States 14 94 0.6× 161 1.2× 268 2.4× 150 1.7× 65 1.1× 18 595
Satoshi Yuasa Japan 13 197 1.2× 280 2.0× 161 1.4× 180 2.0× 25 0.4× 34 598
Martina Leis Germany 7 373 2.3× 56 0.4× 184 1.6× 58 0.7× 82 1.4× 7 565

Countries citing papers authored by Karl Frank

Since Specialization
Citations

This map shows the geographic impact of Karl Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Frank more than expected).

Fields of papers citing papers by Karl Frank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Frank. The network helps show where Karl Frank may publish in the future.

Co-authorship network of co-authors of Karl Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Frank. A scholar is included among the top collaborators of Karl Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Frank. Karl Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sidduri, Achyutharao, Jefferson Tilley, Nadine S. Tare, et al.. (2012). Identification of N-acyl 4-(5-pyrimidine-2,4-dionyl)phenylalanine derivatives and their orally active prodrug esters as dual-acting alpha4–beta1 and alpha4–beta7 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(4). 1026–1031. 5 indexed citations
2.
Tilley, Jefferson, Achyutharao Sidduri, Nadine S. Tare, et al.. (2012). Identification of N-acyl 4-(3-pyridonyl)phenylalanine derivatives and their orally active prodrug esters as dual acting α4β1 and α4β7 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(4). 1036–1040. 9 indexed citations
3.
Reddy, Micaela B., Peter N. Morcos, Sophie Le Pogam, et al.. (2012). Pharmacokinetic/Pharmacodynamic Predictors of Clinical Potency for Hepatitis C Virus Nonnucleoside Polymerase and Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 56(6). 3144–3156. 26 indexed citations
4.
Mikaelian, Igor, Kevin T. Morgan, Erik Rasmussen, et al.. (2008). Temporal Gene Expression Profiling Indicates Early Up-regulation of Interleukin-6 in Isoproterenol-induced Myocardial Necrosis in Rat. Toxicologic Pathology. 36(2). 256–264. 29 indexed citations
5.
Funk, Christoph, et al.. (2005). In vitro studies and computer simulation of interactions between R483, a novel thiazolidinedione, and cytochrome P450 substrates. Clinical Pharmacology & Therapeutics. 77(2). P74–P74. 2 indexed citations
6.
Howard, Kathryn J., Karl Frank, Iain S. Sim, & S F Le Grice. (1991). Reconstitution and properties of homologous and chimeric HIV-1.HIV-2 p66.p51 reverse transcriptase.. Journal of Biological Chemistry. 266(34). 23003–23009. 30 indexed citations
7.
8.
Frank, Karl, Michael J. Holman, Donna M. Huryn, et al.. (1990). Anabolism and Mechanism of Action of Ro24‐5098, an Isomer of 2′,3′‐Dideoxyadenosine (ddA) with Anti‐HIV Activity. Annals of the New York Academy of Sciences. 616(1). 408–414. 5 indexed citations
9.
Huryn, Donna M., S. Y. K. TAM, L. Todaro, et al.. (1990). Synthesis and Anti‐HIV Activity of a Novel Series of Isomeric Dideoxynucleosides. Annals of the New York Academy of Sciences. 616(1). 530–534. 1 indexed citations
10.
Smee, Donald F., Patricia A. McKernan, Karl Frank, et al.. (1988). Antiviral activities of 2′-deoxyribofuranosyl and arabinofuranosyl analogs of sangivamycin against retro- and DNA viruses. Antiviral Research. 10(6). 263–277. 8 indexed citations
11.
Frank, Karl, Patricia A. McKernan, Roberts A. Smith, & Donald F. Smee. (1987). Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides. Antimicrobial Agents and Chemotherapy. 31(9). 1369–1374. 14 indexed citations
12.
Frank, Karl & Ying‐Chih Cheng. (1986). Inhibition of herpes simplex virus DNA polymerase by purine ribonucleoside monophosphates.. Journal of Biological Chemistry. 261(4). 1510–1513. 12 indexed citations
13.
Frank, Karl & Y C Cheng. (1985). Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates. Antimicrobial Agents and Chemotherapy. 27(4). 445–448. 21 indexed citations
14.
Frank, Karl, et al.. (1985). Interaction of DNA polymerase and nucleotide analog triphosphates. Advances in Enzyme Regulation. 24. 377–384. 20 indexed citations
15.
Frank, Karl, David Derse, Kenneth F. Bastow, & Ying‐Chih Cheng. (1984). Novel interaction of aphidicolin with herpes simplex virus DNA polymerase and polymerase-associated exonuclease.. Journal of Biological Chemistry. 259(21). 13282–13286. 30 indexed citations
16.
Frank, Karl, et al.. (1984). Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate.. Journal of Biological Chemistry. 259(3). 1566–1569. 92 indexed citations
17.
Grill, Susan P., et al.. (1984). Effects of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new antiherpesvirus compound, on synthesis of macromolecules in herpes simplex virus-infected cells. Antimicrobial Agents and Chemotherapy. 26(3). 283–288. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan O’Hara Breakdown of academic impact, for papers by Karen Prus Breakdown of academic impact, for papers by Dean W. Selleseth Breakdown of academic impact, for papers by Iain S. Sim Breakdown of academic impact, for papers by Galegov Ga Breakdown of academic impact, for papers by Gussie Arnett Breakdown of academic impact, for papers by Yvonne A. Wilson Breakdown of academic impact, for papers by Christine L. Clouser Breakdown of academic impact, for papers by Satoshi Yuasa Breakdown of academic impact, for papers by Martina Leis
Rankless by CCL
2026